Cogent Biosciences share price today

(COGT)

Cogent Biosciences share price is $7.86 & ₹669.66 as on 25 Dec 2024, 2.30 'hrs' IST

$7.86

▲

0.1

(1.29%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cogent Biosciences share price in Dollar and Rupees. Guide to invest in Cogent Biosciences from India. Also see the sentimental analysis on Indian investors investing in Cogent Biosciences. Get details on the Indian mutual funds that are investing in Cogent Biosciences. Get Analyst recommendations and forecasts along with all the Cogent Biosciences's financials.

Cogent Biosciences share price movements

Today's Low: $7.64
Today's High: $7.88
$7.86
2.86%
Downside
Day's Volatility :3.11%
Upside
0.25%
52 Weeks Low: $4.28
52 Weeks High: $12.61
$7.86
45.55%
Downside
52 Weeks Volatility :66.06%
Upside
37.67%

Cogent Biosciences Returns

Period	Cogent Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-27.89%	-9.0%	0.0%
6 Months	-6.87%	-4.6%	0.0%
1 Year	33.9%	3.0%	0.0%
3 Years	-5.64%	0.0%	-21.1%

Cogent Biosciences Key Statistics

in dollars & INR

Previous Close	$7.76
Open	$7.75
Today's High	$7.88
Today's Low	$7.635
Market Capitalization	$868.2M
Today's Volume	$536.6K
52 Week High	$12.61
52 Week Low	$4.28
Revenue TTM	$0.0
EBITDA	$-258.0M
Earnings Per Share (EPS)	$-2.48
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-78.47%

How to invest in Cogent Biosciences from India?

It is very easy for Indian residents to invest directly in Cogent Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cogent Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cogent Biosciences or COGT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cogent Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cogent Biosciences shares which would translate to 0.108 fractional shares of Cogent Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cogent Biosciences, in just a few clicks!

Returns in Cogent Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Cogent Biosciences investment value today

Current value as on today

₹1,36,140

Returns

₹36,140

(+36.14%)

Returns from Cogent Biosciences Stock

₹33,901 (+33.9%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cogent Biosciences

46%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cogent Biosciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 46% more investors are searching Cogent Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Cogent Biosciences

Point72 Asset Management, L.P.
9.48%
Kynam Capital Management, LP
8.36%
FMR Inc
7.53%
COMMODORE CAPITAL LP
6.83%
BlackRock Inc
6.60%
TCG Crossover Management, LLC
6.30%

Analyst Recommendation on Cogent Biosciences

Buy

82%Buy

17%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Cogent Biosciences(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cogent Biosciences

What analysts predicted

Upside of 113.74%

Current:

$7.86

Target:

$16.80

Insights on Cogent Biosciences

Price Movement
In the last 1 month, COGT stock has moved down by -18.3%
COGT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 35.1%

Cogent Biosciences Technicals Summary

Sell

Neutral

Buy

Cogent Biosciences is currently in a neutral trading position according to technical analysis indicators.

Cogent Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cogent Biosciences Inc	-18.34%	-6.87%	33.9%	-5.64%	1008.6%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cogent Biosciences Inc	NA	NA	NA	-2.4	-0.78	-0.44	NA	1.85
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cogent Biosciences Inc	Buy	$868.2M	1008.6%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Cogent Biosciences

unum therapeutics is a cambridge, massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. unum has built an antibody-coupled t-cell receptor (actr) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic t-lymphocytes (ctls) to kill tumor cells. in contrast to other approaches that hit a single target and treat a narrow set of tumors, unum’s approach is not restricted by antigens and may have applications for treating many types of cancers. unum’s vision: a single cell therapy that can augment the activity of multiple antibodies to treat many different cancers. unum's lead program based on actr technology is currently in phase i clinical testing to assess safety and efficacy in certain forms of leukemia and lymphoma. in parallel, unum is act

Organization	Cogent Biosciences
Employees	164
CEO	Mr. Andrew R. Robbins M.B.A.
Industry	Health Technology

Management People of Cogent Biosciences

Name	Title
Mr. Andrew R. Robbins M.B.A.	President, CEO & Director
Dr. John Edward Robinson Ph.D.	Chief Scientific Officer
Dr. Jessica Sachs M.D.	Chief Medical Officer
Mr. John L. Green C.A., CPA	CFO & Principal Accounting Officer
Mr. Brad Barnett	Chief Technology Officer
Ms. Christi Waarich	Senior Director of Investor Relations
Mr. Evan D. Kearns J.D.	Chief Legal Officer & Corporate Secretary
Ms. Erin Schellhammer	Chief People Officer
Mr. Dana R. Martin Pharm.D.	Senior VP of Medical Affairs & Chief Patient Officer
Brad Fell	Senior Vice President of Chemistry

Important FAQs about investing in Cogent Biosciences from India :

What is Cogent Biosciences share price today?

Cogent Biosciences share price today stands at $7.86, Open: $7.75 ; Previous Close: $7.76 ; High: $7.88 ; Low: $7.64 ; 52 Week High: $12.61 ; 52 Week Low: $4.28. The stock opens at $7.75, after a previous close of $7.76. The stock reached a daily high of $7.88 and a low of $7.64, with a 52-week high of $12.61 and a 52-week low of $4.28.

Can Indians buy Cogent Biosciences shares?

Yes, Indians can invest in the Cogent Biosciences (COGT) from India.

With INDmoney, you can buy Cogent Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cogent Biosciences at zero transaction cost.

How can I buy Cogent Biosciences shares from India?

It is very easy to buy Cogent Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cogent Biosciences be purchased?

Yes, you can buy fractional shares of Cogent Biosciences with INDmoney app.

What are the documents required to start investing in Cogent Biosciences stocks?

To start investing in Cogent Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.